CoChat

Dietary fibre and whole grains in diabetes management: Systematic review and meta-analyses

Open access

The DOI matches its Crossref record; 100 of the 101 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Fibre is promoted as part of a healthy dietary pattern and in diabetes management. We have considered the role of high-fibre diets on mortality and increasing fibre intake on glycaemic control and other cardiometabolic risk factors of adults with prediabetes or diabetes. METHODS AND FINDINGS: We conducted a systematic review of published literature to identify prospective studies or controlled trials that have examined the effects of a higher fibre intake without additional dietary or other lifestyle modification in adults with prediabetes, gestational diabetes, type 1 diabetes, and type 2 diabetes. Meta-analyses were undertaken to determine the effects of higher fibre intake on all-cause and cardiovascular mortality and increasing fibre intake on glycaemic control and a range of cardiometabolic risk factors. For trials, meta regression analyses identified further variables that influenced the pooled findings. Dose response testing was undertaken; Grading of Recommendations Assessment, Development and Evaluation (GRADE) protocols were followed to assess the quality of evidence. Two multicountry cohorts of 8,300 adults with type 1 or type 2 diabetes followed on average for 8.8 years and 42 trials including 1,789 adults with prediabetes, type 1, or type 2 diabetes were identified. Prospective cohort data indicate an absolute reduction of 14 fewer deaths (95% confidence interval (CI) 4-19) per 1,000 participants over the study duration, when comparing a daily dietary fibre intake of 35 g with the average intake of 19 g, with a clear dose response relationship apparent. Increased fibre intakes reduced glycated haemoglobin (HbA1c; mean difference [MD] -2.00 mmol/mol, 95% CI -3.30 to -0.71 from 33 trials), fasting plasma glucose (MD -0.56 mmol/L, 95% CI -0.73 to -0.38 from 34 trials), insulin (standardised mean difference [SMD] -2.03, 95% CI -2.92 to -1.13 from 19 trials), homeostatic model assessment of insulin resistance (HOMA IR; MD -1.24 mg/dL, 95% CI -1.72 to -0.76 from 9 trials), total cholesterol (MD -0.34 mmol/L, 95% CI -0.46 to -0.22 from 27 trials), low-density lipoprotein (LDL) cholesterol (MD -0.17 mmol/L, 95% CI -0.27 to -0.08 from 21 trials), triglycerides (MD -0.16 mmol/L, 95% CI -0.23 to -0.09 from 28 trials), body weight (MD -0.56 kg, 95% CI -0.98 to -0.13 from 18 trials), Body Mass Index (BMI; MD -0.36, 95% CI -0·55 to -0·16 from 14 trials), and C-reactive protein (SMD -2.80, 95% CI -4.52 to -1.09 from 7 trials) when compared with lower fibre diets. All trial analyses were subject to high heterogeneity. Key variables beyond increasing fibre intake were the fibre intake at baseline, the global region where the trials were conducted, and participant inclusion criteria other than diabetes type. Potential limitations were the lack of prospective cohort data in non-European countries and the lack of long-term (12 months or greater) controlled trials of increasing fibre intakes in adults with diabetes. CONCLUSIONS: Higher-fibre diets are an important component of diabetes management, resulting in improvements in measures of glycaemic control, blood lipids, body weight, and inflammation, as well as a reduction in premature mortality. These benefits were not confined to any fibre type or to any type of diabetes and were apparent across the range of intakes, although greater improvements in glycaemic control were observed for those moving from low to moderate or high intakes. Based on these findings, increasing daily fibre intake by 15 g or to 35 g might be a reasonable target that would be expected to reduce risk of premature mortality in adults with diabetes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pmed.1003053

Cites

100 of 100 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 Flow chart indicating the process by which eligible prospective cohort studies and controlled trials were identified.
Fig 1 Flow chart indicating the process by which eligible prospective cohort studies and controlled trials were identified.CC BY · PubMed Central
Fig 2 Dietary fibre intake and all-cause (left) and CVD mortality (right) in cohorts with type 1 or type 2 diabetes. The 95% CIs are shown as dashed lines. Cohort data are presented as country specific estimates when possible. Circle size indicates the weighting of each data point, with bigger circles indicating greater influence. CVD, cardiovascular disease.
Fig 2 Dietary fibre intake and all-cause (left) and CVD mortality (right) in cohorts with type 1 or type 2 diabetes. The 95% CIs are shown as dashed lines. Cohort data are presented as country specific estimates when possible. Circle size indicates the weighting of each data point, with bigger circles indicating greater influence. CVD, cardiovascular disease.CC BY · PubMed Central
Fig 3 Mean difference in glycated haemoglobin (mmol/mol) between intervention and control groups from trials of increasing fibre intakes. Negative values show a decrease in HbA1c when increasing fibre intakes (the intervention). Intervention description is shown in brackets next to the first author’s name and year published in which a trial reported on multiple eligible intervention arms. Medication regimen is also shown in brackets in which the results were reported separately and not as a mean result. ES, effect size; FOS, fructooligosaccharides.
Fig 3 Mean difference in glycated haemoglobin (mmol/mol) between intervention and control groups from trials of increasing fibre intakes. Negative values show a decrease in HbA1c when increasing fibre intakes (the intervention). Intervention description is shown in brackets next to the first author’s name and year published in which a trial reported on multiple eligible intervention arms. Medication regimen is also shown in brackets in which the results were reported separately and not as a mean result. ES, effect size; FOS, fructooligosaccharides.CC BY · PubMed Central
Fig 4 Dose response curves of increasing fibre intakes and key cardiometabolic risk factors. HbA1c (top left, data from 16 trials of 758 participants), fasting glucose (top right, data from 18 trials of 979 participants), total cholesterol (bottom left, data from 25 trials of 1,178 participants), and body weight (bottom right, data from 18 trials of 877 participants) from trials of increasing fibre intakes. The 95% CIs are shown as dashed lines. FPG, fasting plasma glucose.
Fig 4 Dose response curves of increasing fibre intakes and key cardiometabolic risk factors. HbA1c (top left, data from 16 trials of 758 participants), fasting glucose (top right, data from 18 trials of 979 participants), total cholesterol (bottom left, data from 25 trials of 1,178 participants), and body weight (bottom right, data from 18 trials of 877 participants) from trials of increasing fibre intakes. The 95% CIs are shown as dashed lines. FPG, fasting plasma glucose.CC BY · PubMed Central
Fig 5 Mean difference in total cholesterol (mmol/L) between intervention and control groups from trials of increasing fibre intakes. Negative values show a decrease in total cholesterol when increasing fibre intakes (the intervention). ES, effect size; FOS,fructooligosaccharides.
Fig 5 Mean difference in total cholesterol (mmol/L) between intervention and control groups from trials of increasing fibre intakes. Negative values show a decrease in total cholesterol when increasing fibre intakes (the intervention). ES, effect size; FOS,fructooligosaccharides.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 100 references

Research works printed but not linked: 5

  1. Codex Alimentarius, 1985, Guidelines on nutrition labelling, CAC/GL, 2
  2. Veritas Health Innovation. Covidence systematice review software. Melbourne, Australia; 2017.
  3. M Daimon, 2011, Effect of beta-glucan enriched barley flour on impaired glucose tolerance and safety evaluation of the product, Japanese Pharmacology and Therapeutics, 39, 101
  4. Group tEPCS, 2012, Dietary saturated fat and fibre and risk of cardiovascular disease and all-cause mortality among type 1 diabetic patients: the EURODIAB Prospective Complications Study, Diabetologia, 55, 2132, 10.1007/s00125-012-2550-0 · DOI
  5. World Health Organization, 2015, Sugars intake for adults and children: Guideline

Cited by

See all 583

Metadata

Authors
Reynolds, A. N., Akerman, A. P., & Mann, J.
Affiliations
University of Otago (NZ)
Corresponding author
Reynolds, Andrew N.
Venue
PLOS Medicine
Published
2020-03-06
Volume
17
Issue
3
Pages
e1003053
ISSN
  • 1549-1277 (ISSN-L)
  • 1549-1676
OpenAlex
W3009959748
Cited by
567
References
101
Citations by year
2026: 86 · 2025: 114 · 2024: 102 · 2023: 107 · 2022: 75 · 2021: 60 · 2020: 23
FWCI
8.13
Type
journal article
Language
en
Open access
Locations
  • PLoS Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
Funders
  • University of Otago
  • Agence Nationale de la Recherche
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Food composition and properties
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
dietary fiber, whole grains, diabetes management, prediabetes, type 1 diabetes, type 2 diabetes, gestational diabetes mellitus, all-cause mortality, cardiovascular mortality, glycemic control, HbA1c, fasting blood glucose, insulin, insulin resistance, cardiometabolic risk factors, cholesterol, dose-response relationship, dietary recommendations, Mediterranean diet
MeSH terms
Whole Grains, Diet, Healthy, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Diet, Diabetic, Dietary Fiber, Humans, Nutritive Value, Risk Factors, Time Factors, Treatment Outcome, Risk Assessment, Risk Reduction Behavior, Recommended Dietary Allowances, Protective Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Dietary fibre and whole grains in diabetes management: Systematic review and meta-analyses. https://app.cochat.ai/papers/10.1371/journal.pmed.1003053
The paper
Reynolds, A. N., Akerman, A. P., & Mann, J. (2020). Dietary fibre and whole grains in diabetes management: Systematic review and meta-analyses. PLOS Medicine. https://doi.org/10.1371/journal.pmed.1003053

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.